Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Short communication · 17 Sep 2024 Editorial · 23 Sep 2021 T-Cell Lymphoma: Uncontrolled Proliferation of T-Cells
Editorial · 19 Feb 2021 Gamma Delta T-cells (γδ T-cells) and Cancer
Author(s): Oliver Caruso Abstract | Full-Text | PDF
Research article · 9 Jul 2020 Involvement of Fas receptors (CD95) and ligands (CD95L) in CD4+ T-cells and, CD8+ T-cells depletion and hepatic cytolysis in patients with Chronic Viral Hepatitis B
milliliters of blood were collected and analyzed. The CD95, CD95L levels and CD4+, CD8+ T-cell counts were performed by ELISA and Flow cytometry, respectively. The data were analyzed using
Review article · 2019 The T-Cell Predominance: Angioimmunoblastic T-Cell Lymphoma
Short communication · 14 Dec 2018 Angioimmunoblastic T-cell lymphoma: Case report of a diagnostic challenge presented as a lymphoproliferative syndrome
Brazilian woman patient, 51-year-old, born within the State of Bahia
Conference abstract · 29 Aug 2018 Tumor infiltrating cytotoxic CD8 T-Cells predict clinical outcome of neuroblastoma in children
tissue from 36 neuroblastoma from April 2008 to May 2015. The number of CD8+ T-cells was counted in tumor nest (intratumoral) and in the fibrovascular stroma of tumor (peritumoral ... cells (P < 0.097, P < 0.142, and P…
Conference abstract · 12 Jun 2018 Peripheral T-cell lymphoma: Unusually presenting as an auricle mass
present a rare case of peripheral T-cell lymphoma in a 64-year old male presenting with an auricular mass on the right ear with a 7-month history ... repeat incision biopsy revealed atypical round cell lesion…
Conference abstract · 11 May 2018 Optimization of cell culturing condition and cell quality control is essential for engineered T-cell therapy
enabled us to design engineered immune cells using gene editing techniques. Chimeric Antigen Receptor T-cell therapy (CAR-T), one of cell therapies, is the therapy specific for cancer. ... patient are engineered to…
Conference abstract · 6 Nov 2017 The phosphatase JKAP/DUSP22 attenuates T-cell receptor signaling and autoimmunity
Recently, JKAP has been shown to play a critical role in immune regulation. In T-cell receptor (TCR) signaling, JKAP directly inactivates Lck by dephosphorylating tyrosine-394 residue. JKAP-knockout
Conference abstract · 18 Sep 2017 Genome-wide identification of regulatory variation in t-cell prolymphocytic leukemia
T-cell prolymphocytic leukemia (T-PLL) is a rare disease with a median survival of <1 year. T-PLL demonstrates poor response to conventional chemotherapy and inevitable relapse after immunotherapy
Conference abstract · 28 Jul 2016 Intra-tumoral injection of dendritic cells induces specific anti- tumor killer T-cell activity
release of proinflamatory cytokines that support the induction of an antitumor cytotoxic killer T-cells (CTL) by the intra-tumoral injected immature dendritic cells (iDC). The metastatic sites targeted
Conference abstract · 21 Jul 2016 Role of WW domain-containing oxidoreductase WWOX in driving T-cell acute lymphoblastic leukemia maturationRole of WW domain-containing oxidoreductase WWOX in driving T-cell acute lymphoblastic leukemia maturation
Whether tumor suppressor WWOX stimulates immune cell maturation is largely unknown. Here
Conference abstract · 21 Jul 2016 Role of WW domain-containing oxidoreductase WWOX in driving T-cell acute lymphoblastic leukemia maturation
Whether tumor suppressor WWOX stimulates immune cell maturation is largely unknown. Here
Commentary · 2016 A New Controversial Pathophysiology Confirms that HIV does not Kill the CD4+ T-Cell But Mutates Its Physiological Behavior Becoming an Unaccountable CD8+ T-Cell
pathogenesis is known to cause a progressive depilation of CD4+ T-cell cell population in close association with progressive impairment of cellular immunity and increase the susceptibility to infection. This ... virus…
Conference abstract · 28 Sep 2015 Morphofunctional Inactivation of Jurkat T-cells by the Titanium Oxides Coating
have examined response of human leukemic T-lymphoblastoid cells (Jurkat T-cells) to 24-h in vitro cultivation with titanium substrates (12*12*1 mm3) covered by titanium oxides ... CD16, CD56, CD25, CD95) were found at 0…
Conference abstract · 1 Sep 2015 T-cell receptor repertoire of insulin-reactive lymphocytes in type 1 diabetes.
autoimmune destruction of the pancreatic -cells. Autoantigen specifi city is determined by the T-cell receptors (TCRs) of autoreactive lymphocytes but their characteristics are poorly understood. Nextgeneration…
Conference abstract · 8 Jun 2015 HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemia
transcription sustains HTLV-1 viral persistence that ultimately leads to the development of adult T-cell leukemia/lymphoma (ATLL). We hypothesized that besides these quantitative transcriptional effects, HTLV-1…
Research article · 2014 CD4 T-cell Activation and Reduced Regulatory T-cell Populations are Associated with Early Development of Cataracts among HIV-infected Adults in Uganda
innovative therapeutic interventions for cataracts among HIV-positive adults. We compared the regulatory T-cell (Treg) dysfunction among HIV-positive-with-cataracts, HIV-negative-with-cataracts and respectively…
Short communication · 2014 CD25+, CD30+Adult T-Cell Leukemia/Lymphoma cells, Virus-Infected Cells or Regulatory T-Cells?
Conference abstract Hepatitis A virus binding to its cellular receptor 1 (HAVCR1) blocks T-cell receptor and regulatory T-cell function: A novel viral immune escape mechanism
significant allergy and autoimmunity determinant in man. Binding of HAV to HAVCR1 expressed on T-cells prevents the activation of the T-cell receptor and the Akt/PI3K pathway. Human
Perspective · 26 Mar 2026 Regulatory T-Cell Function in Chronic Inflammatory Diseases: Cellular Therapeutic Strategies
Opinion · 29 Dec 2025 Overcoming T-cell Exhaustion: A Tumor Microenvironment Challenge

